European Medicines Agency gives favourable ruling on NSAIDs

BMJ 2006; 333 doi: (Published 26 October 2006) Cite this as: BMJ 2006;333:873
  1. Rory Watson
  1. Brussels

    The London based European Medicines Agency, after a month long investigation, has decided that the benefit-risk balance of non-selective non-steroidal antiinflammatory drugs (NSAIDs) remains favourable.

    The review, which was requested in September by France's national medicines agency, takes account of the publication of new data and analyses on thrombotic cardiovascular safety and develops initial recommendations made …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription